Centiva Capital’s Walgreens Boots Alliance WBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,335,515
Closed -$15.3M 1900
2025
Q2
$15.3M Buy
1,335,515
+120,229
+10% +$1.34M 0.25% 58
2025
Q1
$13.6M Buy
+1,215,286
New +$13.2M 0.41% 23
2024
Q3
Sell
-573
Closed -$6.93K 2647
2024
Q2
$6.93K Sell
573
-51,337
-99% -$871K ﹤0.01% 1992
2024
Q1
$1.13M Buy
+51,910
New +$1.15M 0.03% 610
2023
Q2
Sell
-13,336
Closed -$461K 2036
2023
Q1
$461K Buy
13,336
+3,591
+37% +$127K 0.01% 872
2022
Q4
$364K Buy
+9,745
New +$366K 0.01% 881
2022
Q2
Sell
-12,692
Closed -$568K 2018
2022
Q1
$568K Sell
12,692
-5,140
-29% -$253K 0.01% 923
2021
Q4
$930K Buy
+17,832
New +$864K 0.02% 648
2021
Q3
Sell
-12,666
Closed -$666K 1639
2021
Q2
$666K Buy
12,666
+8,063
+175% +$434K 0.02% 721
2021
Q1
$253K Buy
+4,603
New +$227K 0.01% 872
2020
Q1
Sell
-15,240
Closed -$899K 934
2019
Q4
$899K Sell
15,240
-39,041
-72% -$2.25M 0.04% 303
2019
Q3
$3M Buy
54,281
+49,597
+1,059% +$2.66M 0.18% 111
2019
Q2
$256K Buy
+4,684
New +$249K 0.02% 311

Other funds holding WBA

Centiva Capital's WBA Position: Q3 2025 in Review

Centiva Capital sold out of Walgreens Boots Alliance (WBA) in Q3 2025, closing a stake of 1,335,515 shares — an estimated $15.3M sold.

Centiva Capital first reported a position in WBA in Q2 2019 and held it in 13 quarters. The position peaked at $15.3M in Q2 2025. 9 funds tracked by Wall St. Rank hold WBA as of Q3 2025.

  • Centiva Capital reported no remaining Walgreens Boots Alliance position as of Q3 2025 after selling out during the quarter.
  • Centiva Capital sold 1,335,515 Walgreens Boots Alliance shares in Q3 2025, an estimated $15.3M.
  • Centiva Capital first reported a position in Walgreens Boots Alliance in Q2 2019 and held it in 13 quarters.
  • Centiva Capital's Walgreens Boots Alliance position peaked at $15.3M in Q2 2025.
  • 9 funds tracked by Wall St. Rank held Walgreens Boots Alliance as of Q3 2025.

Based on Centiva Capital's 13F filing for Q3 2025, filed 14 Nov 2025.